Novavax Soars As Its COVID-19 Vaccine Is Found 90% Effective, To Seek FDA OK

Investing.com2021-06-14

Investing.com -- Novavax (NASDAQ:NVAX) shares rose more than 10% in Monday’s premarket trading after the company said a phase-three trial had found its two-dose COVID-19 vaccine to be 90.4% effective....

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • Harris8900
    2021-06-24
    Harris8900
    Good news
  • woonws
    2021-06-15
    woonws
    Good to have another vaccine option!
  • MNCoffee
    2021-06-15
    MNCoffee
    Yo
  • Qlee10
    2021-06-15
    Qlee10
    cool! 
  • Ronchan
    2021-06-15
    Ronchan
    About time…i have been nursing losses on this stock for a while now..onwards and upwards, please…???
  • BlessedCyrus
    2021-06-14
    BlessedCyrus
    Doubt they will get EUA since most American are already vaccinated with MRNA from BioNTech and Moderna? For normal approval from FDA, it should take up till 2022? 
Leave a comment
34